Oakworth Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-461
Closed -$46.7K 663
2025
Q1
$46.7K Hold
461
﹤0.01% 363
2024
Q4
$42.6K Hold
461
﹤0.01% 373
2024
Q3
$44.6K Hold
461
﹤0.01% 361
2024
Q2
$39.5K Buy
+461
New +$38.7K ﹤0.01% 369
2022
Q3
Sell
-419
Closed -$19K 560
2022
Q2
$19K Buy
+419
New +$21.5K ﹤0.01% 383
2020
Q4
Sell
-258
Closed -$13K 579
2020
Q3
$13K Buy
+258
New +$13.2K ﹤0.01% 403
2018
Q3
Sell
-38
Closed -$2K 612
2018
Q2
$2K Hold
38
﹤0.01% 584
2018
Q1
$2K Hold
38
﹤0.01% 558
2017
Q4
$1K Hold
38
﹤0.01% 590
2017
Q3
$1K Buy
+38
New +$1.35K ﹤0.01% 604

Other funds holding EHC

Oakworth Capital's EHC Position: Q2 2025 in Review

Oakworth Capital sold out of Encompass Health (EHC) in Q2 2025, closing a stake of 461 shares — an estimated $46.7K sold.

Oakworth Capital first reported a position in EHC in Q3 2017 and held it in 10 quarters. The position peaked at $46.7K in Q1 2025. 606 funds tracked by Wall St. Rank hold EHC as of Q2 2025.

  • Oakworth Capital reported no remaining Encompass Health position as of Q2 2025 after selling out during the quarter.
  • Oakworth Capital sold 461 Encompass Health shares in Q2 2025, an estimated $46.7K.
  • Oakworth Capital first reported a position in Encompass Health in Q3 2017 and held it in 10 quarters.
  • Oakworth Capital's Encompass Health position peaked at $46.7K in Q1 2025.
  • 606 funds tracked by Wall St. Rank held Encompass Health as of Q2 2025.

Based on Oakworth Capital's 13F filing for Q2 2025, filed 17 Jul 2025.